Stockholders
Frequently Asked Questions
What will happen to the Quorum common stock that I own? Will I receive any compensation if the stock is cancelled?
Under the terms of the Company’s pre-packaged plan, the Company’s stock will be discharged, cancelled, released, and extinguished and of no further force or effect without any distribution on account of such interests. As is typical in a Chapter 11 case, the Company’s stock is expected to be delisted from the NYSE shortly after the Chapter 11 filing and, during the court-supervised process, is being traded over the counter. As of April 7, 2020, trading of the Company’s shares has been halted on the NYSE.
Any recovery to existing stockholders will be ultimately determined in connection with the Company’s Plan of Reorganization upon emergence from Chapter 11. As is typical in most Chapter 11 cases, we do not expect existing Quorum stockholders to receive any recovery at the end of the restructuring process.
Should I sell my Quorum common stock now?
Under the terms of the Company’s pre-packaged plan, the Company’s stock will be discharged, cancelled, released, and extinguished and of no further force or effect without any distribution on account of such interests. Any recovery to existing stockholders will be ultimately determined in connection with the Company’s Plan of Reorganization upon emergence from Chapter 11. As is typical in most Chapter 11 cases, we do not expect existing Quorum stockholders to receive any recovery at the end of the restructuring process.
Investors are urged to consult with their own financial advisors to better understand the implications of the restructuring. It would not be appropriate for the Company to offer investment advice.
Will you hold quarterly earnings reports and host investor conference calls?
As part of the court-supervised process, we will be required to periodically disclose certain financial results. We do not expect to issue earnings press releases or hold quarterly conference calls during the court-supervised process.
UPDATED: April 17, 2020
Watch the June 29 Video Update from Marty Smith:
If you have questions, follow the link below to access court filings and other documents related to the court-supervised proceedings and the toll-free Quorum Health Restructuring Information Line.
Press Releases:
July 7, 2020: Quorum Health Corporation Completes Financial Restructuring, Appoints Joey Jacobs CEO
June 29, 2020: Quorum Health Corporation Receives Court Approval to Complete Prepackaged Recapitalization Plan
April 7, 2020: Quorum Health Corporation Reaches Agreement with Majority of Lenders and Noteholders on Prepackaged Recapitalization Plan
Notice of Patient Care Ombudsman Contact Information
Please take notice that
Daniel T. McMurray, the Patient Care Ombudsman appointed pursuant to an order of the United States Bankruptcy Court, can be reached through the following telephone number and email address:
Telephone: 800-758-9285
PCO email is: [email protected]
All communications are confidential.
Notice of Patient Care Ombudsman Report
Please take notice that Daniel T. McMurray, the patient care ombudsman appointed pursuant to an order of the Court to monitor the quality of patient care and generally to protect the interests of patients, will be electronically filing his first written Ombudsman Report (the “Report”) on June 15, 2020, in the United States Bankruptcy Court for the District of Delaware.
If you would like a copy of the Report, please contact:
Stephanie Gibbons, Legal Assistant
NEUBERT, PEPE & MONTEITH, P.C.
195 Church Street, 13th Floor
New Haven, Connecticut 06510
Telephone: 203-821-2000
Email: [email protected]
Media Contacts:
Investor Relations/Corporate Media Relations:
Rosemary Plorin
Lovell Communications
615-750-9025
email: [email protected]
Hospital Media Relations:
Please contact your local hospital marketing director.